MX2018005460A - Pheromone composition to stimulate reproduction in female suids and methods of use. - Google Patents

Pheromone composition to stimulate reproduction in female suids and methods of use.

Info

Publication number
MX2018005460A
MX2018005460A MX2018005460A MX2018005460A MX2018005460A MX 2018005460 A MX2018005460 A MX 2018005460A MX 2018005460 A MX2018005460 A MX 2018005460A MX 2018005460 A MX2018005460 A MX 2018005460A MX 2018005460 A MX2018005460 A MX 2018005460A
Authority
MX
Mexico
Prior art keywords
methods
pheromone composition
composition
suids
female
Prior art date
Application number
MX2018005460A
Other languages
Spanish (es)
Inventor
J Mcglone John
Original Assignee
Univ Texas Tech System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57189311&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2018005460(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Texas Tech System filed Critical Univ Texas Tech System
Publication of MX2018005460A publication Critical patent/MX2018005460A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01—Other fatty acid esters, e.g. phosphatides
    • A23D7/011—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/184—Hormones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Birds (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Catching Or Destruction (AREA)

Abstract

The present disclosure provides for compositions and methods of stimulating reproductive behavior and reproductive success and productivity in a suid, such as pigs. The composition may comprise at least one steroid hormone and a heterocyclic aromatic compound. The method comprises administering the pheromone composition to the suid for a period of time.
MX2018005460A 2015-11-17 2016-11-16 Pheromone composition to stimulate reproduction in female suids and methods of use. MX2018005460A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/943,607 US9480689B1 (en) 2015-11-17 2015-11-17 Pheromone composition to stimulate reproduction in female suids and methods of use
PCT/US2016/062199 WO2017087468A1 (en) 2015-11-17 2016-11-16 Pheromone composition to stimulate reproduction in female suids and methods of use

Publications (1)

Publication Number Publication Date
MX2018005460A true MX2018005460A (en) 2018-09-18

Family

ID=57189311

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018005460A MX2018005460A (en) 2015-11-17 2016-11-16 Pheromone composition to stimulate reproduction in female suids and methods of use.

Country Status (19)

Country Link
US (1) US9480689B1 (en)
EP (1) EP3377069B1 (en)
JP (1) JP6486562B2 (en)
KR (1) KR101951915B1 (en)
CN (1) CN108289898B (en)
AU (1) AU2016358182B2 (en)
BR (1) BR112018008549B1 (en)
CA (1) CA3004465C (en)
DK (1) DK3377069T3 (en)
ES (1) ES2831711T3 (en)
HK (1) HK1257537A1 (en)
HU (1) HUE051885T2 (en)
MX (1) MX2018005460A (en)
PH (1) PH12018501002A1 (en)
PL (1) PL3377069T3 (en)
PT (1) PT3377069T (en)
RU (1) RU2684717C1 (en)
UA (1) UA121147C2 (en)
WO (1) WO2017087468A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9480689B1 (en) * 2015-11-17 2016-11-01 Animal Biotech, LLC Pheromone composition to stimulate reproduction in female suids and methods of use
BR112019002250A2 (en) 2016-08-02 2019-05-14 Texas Tech University System composition, method of modifying behavior in an animal, and method for modifying behavior in a dog
MX2020006269A (en) 2017-12-13 2020-09-07 Univ Texas Tech System Pheromone compositions for stimulating early onset of estrus and reducing labor needs in breeding peri-pubertal suids and methods of use.
GB2604052A (en) * 2019-09-19 2022-08-24 Univ Texas Tech System Swine maternal neonatal pheromone
CN112370528B (en) * 2020-10-23 2022-04-08 宁波三生生物科技股份有限公司 Pheromone composition with marking function and preparation thereof
CN113332295B (en) * 2021-05-10 2022-09-06 宁波三生生物科技股份有限公司 Pheromone composition for improving sow heat-checking efficiency
CN114533740B (en) * 2022-02-10 2024-04-12 广州威生医药科技有限公司 Boar odorant composition and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110489A (en) * 1998-05-01 2000-08-29 Cutler; Neal R. Use of quinolines and quinolones to treat male erectile dysfunction
US6194433B1 (en) * 1998-10-05 2001-02-27 Neal R. Cutler Sexual dysfunction in females
RU2183640C1 (en) * 2001-07-11 2002-06-20 Зинкевич Эдуард Петрович 2α-METHYL-5ALPHA-ANDROST-16-EN-3-ON AS OLFACTORY STIMULANT OF REPRODUCTIVE FUNCTIONS IN FEMALE SWINE AND COWS
US20060252738A1 (en) * 2005-05-06 2006-11-09 Phero Tech Inc. Method for preparing and using water-based steroid pheromone compositions
CN101797257A (en) * 2010-01-20 2010-08-11 中国科学院上海有机化学研究所 Hormone preparation for sow aphrodisiac
MX338628B (en) * 2011-09-20 2016-04-26 Sergeants Pet Care Prod Inc Interomone compositions and their use to modify behavior in different vertebrate species.
US9480689B1 (en) * 2015-11-17 2016-11-01 Animal Biotech, LLC Pheromone composition to stimulate reproduction in female suids and methods of use

Also Published As

Publication number Publication date
AU2016358182B2 (en) 2021-09-09
PT3377069T (en) 2020-11-19
EP3377069B1 (en) 2020-09-30
PH12018501002A1 (en) 2018-12-17
PL3377069T3 (en) 2021-06-14
DK3377069T3 (en) 2020-10-12
KR20180084054A (en) 2018-07-24
BR112018008549A2 (en) 2018-10-23
US9480689B1 (en) 2016-11-01
EP3377069A4 (en) 2019-07-03
KR101951915B1 (en) 2019-02-25
CA3004465A1 (en) 2017-05-26
CN108289898A (en) 2018-07-17
ES2831711T3 (en) 2021-06-09
HUE051885T2 (en) 2021-04-28
WO2017087468A1 (en) 2017-05-26
JP6486562B2 (en) 2019-03-20
JP2018533576A (en) 2018-11-15
CA3004465C (en) 2019-02-19
RU2684717C1 (en) 2019-04-11
EP3377069A1 (en) 2018-09-26
AU2016358182A1 (en) 2018-05-10
HK1257537A1 (en) 2019-10-25
CN108289898B (en) 2020-05-15
UA121147C2 (en) 2020-04-10
BR112018008549B1 (en) 2021-02-23

Similar Documents

Publication Publication Date Title
PH12018501002A1 (en) Pheromone composition to stimulate reproduction in female suids and method of use
PH12017501956A1 (en) Compositions of obeticholic acid and methods of use
PH12017500583A1 (en) Dihydropyrrolopyridine inhibitors of ror-gamma
PH12016501457A1 (en) Dihydropyrrolopyridine inhibitors of ror-gamma
NZ732154A (en) Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
NZ729678A (en) Methods of treating non-alcoholic steatohepatitis using ask1 inhibitor in combination with a fxr agonist
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
MX2016011841A (en) Topical corticosteroid compositions.
AR105645A1 (en) COMPOSITIONS THAT INCLUDE ACID COMPLAINANT TO TREAT UNDERGROUND FORMATIONS THAT INCLUDE ONE OR MORE FRACTURES
PH12016502003B1 (en) Novel bacteriophage and composition containing same
MX2017016517A (en) Storage stable compositions and methods for the treatment of refractive errors of the eye.
EP3332012A4 (en) Glp-1 and use thereof in compositions for treating metabolic diseases
MX2015012111A (en) Ship1 modulators and methods related thereto.
NZ722600A (en) Methods of treating mild brain injury
MX2021010989A (en) Formulation including a combination of î²-endorphin and adrenocorticotropic hormone.
PH12015501187A1 (en) Method for synchronizing time of insemination in gilts
MX2022015141A (en) Compositions and methods of use of an inappetance-controlling compound.
PE20170770A1 (en) METHODS AND COMPOSITIONS FOR TREATING HIV-RELATED DISORDERS
MX2016009600A (en) Agents for use in the treatment of retinal inflammation.
MX2022014763A (en) Compositions of grapiprant and methods for using the same.
PH12020550907A1 (en) Pheromone compositions for stimulating early onset of estrus and reducing labor needs in breeding peri-pubertal suids and methods of use
MX2016016039A (en) Pharmaceutical formulation for reducing frequency of urination and method of use thereof.
MX2016004392A (en) Dual breaker system for reducing formation damage during fracturing.
MX2018005100A (en) Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders.